Comparing two methods for inducing labor in pregnancies with fetal growth restriction
Official title: Prostaglandins Versus Trans-Cervical Balloon for Induction of Labor in Fetal Growth Restriction: a Multicenter Open-label Randomized Trial
Run by University Hospital, Bordeaux · NCT05674487 · Data updated 2026-11-12
This study is testing whether using a balloon to help start labor is better than using medication for women with babies that aren't growing well, to see if it leads to fewer C-sections and healthier babies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 774 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Bordeaux) |
| Status | Recruiting |
| Started | April 9, 2024 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | April 2, 2025 |
| Trial ID | NCT05674487 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women over 18 years old with singleton gestation and fetal growth restriction, indicated by specific ultrasound measurements.
✕Probably not a fit
Patients who have contraindications to labor induction or a history of previous cesarean deliveries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial aims to compare the effectiveness of two cervical ripening methods, trans-cervical balloon and prostaglandins, in women with fetal growth restriction. The primary objective is to determine whether the trans-cervical balloon method results in a lower cesarean section rate without increasing neonatal morbidity. Participants will be randomly assigned to receive either the trans-cervical balloon or prostaglandins for labor induction. The study addresses a significant gap in current guidelines regarding the optimal induction method for this high-risk population.
Why it matters
Potential benefit: If successful, this study could lead to safer labor induction practices for women with fetal growth restriction, potentially reducing cesarean delivery rates and improving neonatal outcomes.
How similar studies have gone: While some retrospective studies suggest advantages of the trans-cervical balloon over prostaglandins, this trial is among the first to rigorously compare these methods in the context of fetal growth restriction.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18 years * Singleton gestation, with cephalic presentation * Gestational age at randomization between entre 34 weeks of gestation and 0 day and 41 weeks of gestation and 0 day * Fetal growth restriction (FGR). FGR is defined at the third trimester by an abdominal circumference below the 10th centile and/or an estimated fetal weight below the 10th centile (according to local curve), according to the trial DIGITAT. Fetus with normal and abnormal Doppler index can be included. * Plan for induction of labor whatever the indication (fetal growth restriction or other), the induction of labor is the induction of birth by vaginal delivery * Bishop Score below 6 * Affiliated or beneficiary to a health security system * Signed informed consent Exclusion Criteria: * Contraindication to an induction of labor * History of previous cesarean delivery, myomectomy by laparotomy or laparoscopy * Contraindication to misoprostol or trans-cervical balloon * Known HIV positivity (because of modified delivery plan) * Known major fetal anomaly or chromosomic anomaly * Fetal demise * Patient under legal protection * Poor understanding of the French language
Where it's running
-
CHU Bordeaux
Bordeaux, France Recruiting
Study contacts
- Study coordinator: Hanane Bouchghoul, MD
- Email: hanane.bouchghoul@chu-bordeaux.fr
- Phone: +335 57 82 16 12
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fetal Heart Function in Growth-Restricted Pregnancies
This study tests whether fetal echocardiography using a modified Tei index (Mod-MPI) can reveal early heart changes in pregnancies affected by fetal growth restriction (IUGR).
-
Combined first-trimester screening for pregnancy complications
This project tests a standardized first-trimester screening to see if it can identify pregnant women at 11–13 weeks who are at higher risk for preeclampsia, fetal growth restriction, chromosomal problems, and other serious complications.
-
Left-side positioning for pregnancies with fetal growth restriction
This trial tests whether pregnant people with fetal growth restriction who lie on their left side for several hours a day help their baby grow better and affect maternal and fetal health measures.
-
Examining placental blood flow using contrast ultrasound in pregnancies with growth restriction
This study is testing how well blood flows in the placenta of women having a medical termination of pregnancy, comparing those with and without fetal growth restriction to learn more about these conditions.
-
L-citrulline supplementation during pregnancy to reduce adverse birth outcomes in Kenyan women at risk of malaria.
This trial will test whether taking a twice-daily L-citrulline supplement during pregnancy helps Kenyan women at risk of malaria have healthier pregnancies and babies.
-
Using echocardiography to diagnose fetal growth issues in twin pregnancies
This study is testing if a special heart ultrasound can help doctors spot growth problems in twins before they are born, while also looking at how air pollution might affect their health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.